You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plaque, Amyloid

Showing 1 - 25 of 3,042
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cognitive Health in Ageing Register: Investigational,

Active, not recruiting
  • Alzheimer's Disease
  • Plaque, Amyloid
    • Edinburgh, United Kingdom
    • +1 more
    Jan 31, 2023

    Breast Cancer Trial in Salt Lake City ([18F]Flutemetamol, [18F]fluoro-2-deoxy-D-glucose (FDG), Functional Magnetic Resonance

    Recruiting
    • Breast Cancer
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Feb 3, 2022

    Post-stroke Dementia, Vascular Mild Cognitive Impairment Trial in Taoyuan ([18F]THK-5351, [18F]AV-45)

    Recruiting
    • Post-stroke Dementia, Vascular Mild Cognitive Impairment
    • Taoyuan, Guishan, Taiwan
      Department of Neurology, Chang-Gung memorial Hospital
    Oct 3, 2021

    Amyloid, Systemic Amyloidosis Trial in Champigny-sur-Marne (MRI)

    Recruiting
    • Amyloid
    • Systemic Amyloidosis
    • MRI
    • Champigny-sur-Marne, France
      Hôpital Privé Paul d'Egine
    Nov 25, 2021

    Post-stroke Dementia, Vascular Mild Cognitive Impairment Trial in Taoyuan (THK-5351, AV-45)

    Completed
    • Post-stroke Dementia
    • Vascular Mild Cognitive Impairment
    • Taoyuan, Guishan, Taiwan
      Department of Neurology, Chang-Gung memorial Hospital
    Oct 3, 2021

    Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal Dementia Trial in Taoyuan (PMPBB3, AV45)

    Recruiting
    • Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal Dementia
    • Taoyuan, Guishan, Taiwan
      Department of Neurology, Chang-Gung memorial Hospital
    Oct 3, 2021

    Cardiac Amyloidosis Trial in Vandœuvre-lès-Nancy (Neuraceq PET/CT imaging)

    Recruiting
    • Cardiac Amyloidosis
    • Neuraceq PET/CT imaging
    • Vandœuvre-lès-Nancy, France
      Chru Nancy
    Dec 21, 2021

    Alzheimer's Disease, Prodromal Alzheimer's Disease, Amyloid Plaque Trial in Liverpool, London (Placebo, ACI-24.060 at Dose A,

    Recruiting
    • Alzheimer's Disease
    • +4 more
    • Placebo
    • +6 more
    • Liverpool, United Kingdom
    • +1 more
    Jul 13, 2022

    Cognitive Impairment, Mild, Cognitive Dysfunction, Amyloid Plaque Trial in Phoenix, Las Vegas (Lenalidomide 10 mg, Placebo)

    Recruiting
    • Cognitive Impairment, Mild
    • +4 more
    • Lenalidomide 10 mg
    • Placebo
    • Phoenix, Arizona
    • +1 more
    Apr 14, 2022

    Alzheimer, Amyloid Plaque, Amyloidosis Trial (40 Hz multi-sensory (auditory + visual) stimulation and cognitive training,

    Not yet recruiting
    • Alzheimer Disease
    • +2 more
    • 40 Hz multi-sensory (auditory + visual) stimulation and cognitive training
    • Cognitive training
    • (no location specified)
    May 28, 2021

    Late Onset Alzheimer Trial in New York (BAY 94-9172 (Florbetaben))

    Active, not recruiting
    • Late Onset Alzheimer Disease
    • BAY 94-9172 (Florbetaben)
    • New York, New York
      Columbia University Medical Center
    Feb 11, 2022

    Amyloid Plaque and Tangle Imaging in Aging and Dementia

    Completed
    • Memory Disorders
    • Alzheimer's Disease
      • Los Angeles, California
        Jane & Terry Semel Institute for Neuroscience & Human Behavior
      May 4, 2020

      Cognitive Impairment, Carotid Artery Plaque, Inflammation Trial in Salt Lake City (Imaging with flutemetamol F 18 PET/CT)

      Recruiting
      • Cognitive Impairment
      • +2 more
      • Imaging with flutemetamol F 18 PET/CT
      • Salt Lake City, Utah
      • +1 more
      Apr 26, 2021

      Mild Cognitive Impairment, Alzheimer Trial in United States (Donanemab, Aducanumab)

      Active, not recruiting
      • Mild Cognitive Impairment
      • Alzheimer Disease
      • Fullerton, California
      • +30 more
      Jan 18, 2023

      Florbetaben for Imaging of Vascular Amyloid

      Recruiting
      • Acute Coronary Syndrome
      • +3 more
        • Ottawa, Ontario, Canada
          University of Ottawa Heart Institute
        Oct 13, 2023

        Alzheimer Trial in Boston (Transcranial Alternating Current Stimulation (tACS))

        Completed
        Has Results
        • Alzheimer Disease
        • Transcranial Alternating Current Stimulation (tACS)
        • Boston, Massachusetts
          Beth Israel Deaconess Medical Center
        Aug 18, 2022

        Alzheimer's Disease, Mild Cognitive Impairment Trial in Amsterdam (VX-745)

        Completed
        Has Results
        • Alzheimer's Disease
        • Mild Cognitive Impairment
        • Amsterdam, Netherlands
          Alzheimer Research Center, VU Medical Center
        Mar 13, 2019

        Bioavailability, Gut Microbiome, Safety Trial in Lubbock (Low curcumin group, High curcumin group)

        Not yet recruiting
        • Bioavailability
        • +2 more
        • Low curcumin group
        • High curcumin group
        • Lubbock, Texas
          Texas Tech University Health Sciences Center
        Mar 15, 2023

        Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Matching Placebo (Gantenerumab))

        Suspended
        • Alzheimers Disease
        • +2 more
        • Birmingham, Alabama
        • +34 more
        Jan 10, 2023

        Mild Cognitive Impairment Trial in Philadelphia (11C-acetate)

        Terminated
        • Mild Cognitive Impairment
        • Philadelphia, Pennsylvania
          University of Pennsylvania
        Apr 11, 2022

        Cognition Disorders Trial in Worldwide (Placebo, Solanezumab)

        Active, not recruiting
        • Cognition Disorders
        • Birmingham, Alabama
        • +67 more
        Jan 17, 2023

        Alzheimer Trial in New Haven (Amyvid)

        Recruiting
        • Alzheimer Disease
        • New Haven, Connecticut
          Invicro
        Dec 7, 2021

        Alzheimer's Disease (AD) Trial in Italy, Portugal, United States (ABBV-916, Placebo)

        Recruiting
        • Alzheimer's Disease (AD)
        • Phoenix, Arizona
        • +87 more
        Dec 29, 2022

        Mild Cognitive Impairment, Biomarker, Diagnosis Trial in Shanghai (Huperzine A, Placebo)

        Not yet recruiting
        • Mild Cognitive Impairment
        • +3 more
        • Huperzine A
        • Placebo
        • Shanghai, Shanghai, China
          Shanghai Mental Health Center
        Apr 13, 2019

        Parkinson Disease Trial in Ann Arbor (Citalopram 20mg, Placebo)

        Recruiting
        • Parkinson Disease
        • Citalopram 20mg
        • Placebo
        • Ann Arbor, Michigan
          University of Michigan
        Mar 30, 2022